Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia

Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particul...

Full description

Saved in:
Bibliographic Details
Published inBMC public health Vol. 12; no. 1; p. 282
Main Authors Ambaw, Abere Dessie, Alemie, Getahun Asres, W/Yohannes, Solomon Meseret, Mengesha, Zelalem Birhanu
Format Journal Article
LanguageEnglish
Published London BioMed Central 10.04.2012
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-2458
1471-2458
DOI10.1186/1471-2458-12-282

Cover

Abstract Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Method Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. Results More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Conclusion Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
AbstractList Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
Doc number: 282 Abstract Background : Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Method : Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. Results : More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Conclusion : Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Method Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. Results More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Conclusion Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
Abstract Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Method Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. Results More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Conclusion Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital.BACKGROUNDHypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital.Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16.METHODInstitution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16.More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence.RESULTSMore than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence.Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.CONCLUSIONOnly 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Method Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. Results More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Conclusion Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral Hospital. Institution based cross sectional study was conducted. Systematic sampling technique was used to select 384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed using SPSS version 16. More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex (AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were found significantly associated with treatment adherence. Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex, distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and patient education about the disease and its treatment are important to improve adherence status of patients.
ArticleNumber 282
Audience Academic
Author Mengesha, Zelalem Birhanu
Alemie, Getahun Asres
W/Yohannes, Solomon Meseret
Ambaw, Abere Dessie
AuthorAffiliation 1 College of Medicine and Health Sciences, University of Gondar, Gondar, P.O.Box 196, Ethiopia
2 Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, P.O.Box 196, Ethiopia
3 Department of Reproductive Health, Institute of Public Health, University of Gondar, Gondar, P.O.Box 196, Ethiopia
AuthorAffiliation_xml – name: 1 College of Medicine and Health Sciences, University of Gondar, Gondar, P.O.Box 196, Ethiopia
– name: 2 Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar, Gondar, P.O.Box 196, Ethiopia
– name: 3 Department of Reproductive Health, Institute of Public Health, University of Gondar, Gondar, P.O.Box 196, Ethiopia
Author_xml – sequence: 1
  givenname: Abere Dessie
  surname: Ambaw
  fullname: Ambaw, Abere Dessie
  organization: College of Medicine and Health Sciences, University of Gondar
– sequence: 2
  givenname: Getahun Asres
  surname: Alemie
  fullname: Alemie, Getahun Asres
  organization: Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar
– sequence: 3
  givenname: Solomon Meseret
  surname: W/Yohannes
  fullname: W/Yohannes, Solomon Meseret
  organization: Department of Epidemiology and Biostatistics, Institute of Public Health, University of Gondar
– sequence: 4
  givenname: Zelalem Birhanu
  surname: Mengesha
  fullname: Mengesha, Zelalem Birhanu
  email: zelalem78@gmail.com
  organization: Department of Reproductive Health, Institute of Public Health, University of Gondar
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22490130$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1v1DAQhiNURD_gzglZ4sKBLbETJ84FqVqVtlIFF3q2Js5k11XiCba31f4K_jJetlS7VYt8iDXzzuPMO3OcHThymGXveX7Kuaq-8LLmM1FKNeNiJpR4lR09hg527ofZcQi3ec5rJcWb7FCIssl5kR9lv8-6JXp0BlkkBi7a5XpCH9EFe5diHiGO6GJKdQxCIGMhYsd6MJF8YDCSW7AJok2iwMixnoaB7tlqYhDZjUsUH2xcM-rZBbkOPLukMNkIw2f2nXxc3mOI7DwuLU0W3mavexgCvnv4nmQ3385_zi9n1z8uruZn17O2kk2ctaVqedd2UvYoVC6kyRFNB7U0dSt43nY9ogTspSgBmh6hKmWulKp5WTSVKE6yqy23I7jVk7cj-LUmsPpvgPxCg4_WDKhRqbJpOSK0vEQl2kZVUNQCEISUqkisr1vWtGpH7ExywsOwB93POLvUC7rTRdFIWVUJMN8CWksvAPYzhka9Ga7eDFdzodPsE-XTw294-rVKpurRBoPDAA5pFTSXklecN6VM0o9PpLe08i4Zrnku6qKuVL2jWkCywbqe0uNmA9Vnsii5VE216f70GVU6HY7WpH3tbYrvFXzYteuxzX9LmQT5VmA8heCxf5TwXG_2_rneqyclJm1YtLTxyw7_K-TbwpDecAv0u068UPMHMtEXvA
CitedBy_id crossref_primary_10_1038_s41598_024_80086_x
crossref_primary_10_1371_journal_pone_0130193
crossref_primary_10_1186_s12889_024_20733_0
crossref_primary_10_1186_s43044_020_00044_6
crossref_primary_10_2147_IBPC_S339773
crossref_primary_10_1590_0104_07072016000560015
crossref_primary_10_1136_bmjopen_2019_036418
crossref_primary_10_1155_2022_5962571
crossref_primary_10_2174_1874944501811010062
crossref_primary_10_1186_s41182_021_00374_4
crossref_primary_10_1161_CIRCULATIONAHA_121_056161
crossref_primary_10_1371_journal_pone_0193494
crossref_primary_10_1371_journal_pone_0259421
crossref_primary_10_1111_jch_12646
crossref_primary_10_22159_ajpcr_2024v17i9_52286
crossref_primary_10_1371_journal_pone_0227874
crossref_primary_10_1186_s12889_018_5637_9
crossref_primary_10_1371_journal_pone_0166432
crossref_primary_10_1007_s40267_020_00744_8
crossref_primary_10_1016_j_jvn_2013_09_002
crossref_primary_10_4103_ijcfm_ijcfm_20_23
crossref_primary_10_1093_jphsr_rmae030
crossref_primary_10_1136_heartasia_2018_011136
crossref_primary_10_1136_bmjopen_2016_015743
crossref_primary_10_2147_PPA_S243665
crossref_primary_10_1016_j_ccl_2016_08_008
crossref_primary_10_1016_j_pec_2019_02_022
crossref_primary_10_1371_journal_pone_0295246
crossref_primary_10_4236_ojcd_2021_112002
crossref_primary_10_1177_1074248418784292
crossref_primary_10_1016_j_jegh_2014_05_005
crossref_primary_10_1155_2016_8579157
crossref_primary_10_20473_jfiki_v8i12021_46_57
crossref_primary_10_5334_aogh_2904
crossref_primary_10_1186_s41043_017_0090_4
crossref_primary_10_2147_PPA_S319987
crossref_primary_10_2147_PPA_S238751
crossref_primary_10_51957_Healthline_189_2020
crossref_primary_10_1080_14787210_2019_1689818
crossref_primary_10_1007_s40119_016_0079_x
crossref_primary_10_1038_jhh_2016_31
crossref_primary_10_26442_00403660_2021_12_201172
crossref_primary_10_1161_CIRCRESAHA_117_311849
crossref_primary_10_1186_s40360_017_0134_9
crossref_primary_10_1371_journal_pmed_1001490
crossref_primary_10_3389_fphar_2019_00168
crossref_primary_10_7759_cureus_36345
crossref_primary_10_1186_s12889_017_4646_4
crossref_primary_10_1186_s40885_018_0104_6
crossref_primary_10_1371_journal_pone_0301547
crossref_primary_10_1007_s10557_017_6756_8
crossref_primary_10_1016_j_ijans_2022_100404
crossref_primary_10_1186_s12872_018_0769_5
crossref_primary_10_1016_j_gheart_2015_04_006
crossref_primary_10_1007_s10557_017_6753_y
crossref_primary_10_1016_j_hlc_2021_04_010
crossref_primary_10_1186_s13104_018_3139_6
crossref_primary_10_3390_life11060528
crossref_primary_10_1177_2048004019892758
crossref_primary_10_1155_2020_9540810
crossref_primary_10_1186_s40885_020_00151_1
crossref_primary_10_1371_journal_pone_0196535
crossref_primary_10_3389_ijph_2022_1604599
crossref_primary_10_3897_pharmacia_70_e109440
crossref_primary_10_1161_CIRCULATIONAHA_115_008722
crossref_primary_10_1016_j_refiri_2021_100233
crossref_primary_10_1111_jch_13873
crossref_primary_10_17533_udea_rfnsp_v33n2a06
crossref_primary_10_1177_2050312120982459
crossref_primary_10_3389_fpubh_2023_1104510
crossref_primary_10_1371_journal_pone_0273655
crossref_primary_10_4103_njcp_njcp_1678_21
crossref_primary_10_4236_jbm_2022_105017
crossref_primary_10_1155_2020_4392058
crossref_primary_10_1097_MD_0000000000026818
crossref_primary_10_3389_fmed_2024_1369569
crossref_primary_10_52494_MOEL1486
crossref_primary_10_1186_1471_2261_14_102
crossref_primary_10_1016_j_hjdsi_2015_08_002
crossref_primary_10_1097_MD_0000000000032171
crossref_primary_10_17352_ach_000028
crossref_primary_10_1111_ijcp_13044
crossref_primary_10_4103_jncd_jncd_34_19
Cites_doi 10.1161/01.HYP.0000252676.46043.18
10.1310/89E2-XNJL-W107-R2GL
10.1001/jama.290.2.199
10.1097/00149831-200506000-00010
10.1097/00004872-200401000-00003
10.1097/01.hco.0000126978.03828.9e
10.1038/sj.jhh.1001050
10.1161/01.HYP.0000107251.49515.c2
10.3109/10641969309037087
10.1097/01.mlr.0000166617.68751.5f
10.1186/1471-2261-9-39
10.1097/00005650-198601000-00007
10.1371/journal.pone.0000280
10.1016/S0140-6736(05)70151-3
10.1186/1744-859X-5-6
10.1097/01.hjh.0000226210.95936.bc
10.1111/j.2042-7174.2001.tb01068.x
10.1038/sj.jhh.1001981
ContentType Journal Article
Copyright Ambaw et al.; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
COPYRIGHT 2012 BioMed Central Ltd.
2012 Ambaw et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright ©2012 Ambaw et al.; licensee BioMed Central Ltd. 2012 Ambaw et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: Ambaw et al.; licensee BioMed Central Ltd. 2012 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: COPYRIGHT 2012 BioMed Central Ltd.
– notice: 2012 Ambaw et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
– notice: Copyright ©2012 Ambaw et al.; licensee BioMed Central Ltd. 2012 Ambaw et al.; licensee BioMed Central Ltd.
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7X7
7XB
88E
8C1
8FE
8FG
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
AN0
ATCPS
AZQEC
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
L6V
M0S
M1P
M7S
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
7X8
5PM
DOA
DOI 10.1186/1471-2458-12-282
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Materials Science & Engineering Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
British Nursing Index
Agricultural & Environmental Science Collection
ProQuest Central Essentials
ProQuest Central
Technology Collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Engineering Collection
ProQuest Health & Medical Collection
Medical Database
Engineering Database
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering Collection
Environmental Science Collection
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
Technology Collection
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
ProQuest Engineering Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Engineering Database
ProQuest Public Health
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Environmental Science Collection
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Materials Science & Engineering Collection
Environmental Science Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database


MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
EISSN 1471-2458
EndPage 282
ExternalDocumentID oai_doaj_org_article_e8849b1eeab14e82b986a372aea25583
PMC3395566
oai_biomedcentral_com_1471_2458_12_282
2717820361
A534158963
22490130
10_1186_1471_2458_12_282
Genre Journal Article
GeographicLocations Ethiopia
GeographicLocations_xml – name: Ethiopia
GroupedDBID ---
0R~
23N
2VQ
2WC
2XV
4.4
44B
53G
5VS
6J9
6PF
7X7
7XC
88E
8C1
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABJCF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AN0
AOIJS
ATCPS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BGLVJ
BHPHI
BMC
BNQBC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EJD
EMB
EMK
EMOBN
ESTFP
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
L6V
M1P
M48
M7S
M~E
O5R
O5S
OK1
OVT
P2P
PATMY
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PTHSS
PUEGO
PYCSY
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
7T2
7XB
8FK
AZQEC
C1K
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ABVAZ
AFGXO
AFNRJ
5PM
ID FETCH-LOGICAL-b659t-b48b1dbd55fe28025c0eecda75c7b210bdfee5aef524aa9fea645088871439623
IEDL.DBID M48
ISSN 1471-2458
IngestDate Wed Aug 27 01:26:14 EDT 2025
Thu Aug 21 13:50:04 EDT 2025
Wed May 22 07:15:36 EDT 2024
Mon Sep 08 07:09:49 EDT 2025
Fri Jul 25 10:39:35 EDT 2025
Tue Jun 17 22:05:29 EDT 2025
Mon Jul 21 10:57:44 EDT 2025
Wed Feb 19 01:51:31 EST 2025
Tue Jul 01 04:09:22 EDT 2025
Thu Apr 24 23:02:30 EDT 2025
Sat Sep 06 07:22:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Adherence Behavior
Patient Provider Relationship
Adherence Status
Adherence Counseling
Chronic Illness Care
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b659t-b48b1dbd55fe28025c0eecda75c7b210bdfee5aef524aa9fea645088871439623
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/1471-2458-12-282
PMID 22490130
PQID 1027376875
PQPubID 44782
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_e8849b1eeab14e82b986a372aea25583
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3395566
biomedcentral_primary_oai_biomedcentral_com_1471_2458_12_282
proquest_miscellaneous_1551611945
proquest_journals_1027376875
gale_infotracmisc_A534158963
gale_infotracacademiconefile_A534158963
pubmed_primary_22490130
crossref_primary_10_1186_1471_2458_12_282
crossref_citationtrail_10_1186_1471_2458_12_282
springer_journals_10_1186_1471_2458_12_282
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2012-04-10
PublicationDateYYYYMMDD 2012-04-10
PublicationDate_xml – month: 04
  year: 2012
  text: 2012-04-10
  day: 10
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle BMC public health
PublicationTitleAbbrev BMC Public Health
PublicationTitleAlternate BMC Public Health
PublicationYear 2012
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References Baune, Aljeesh (CR17) 2006; 5
Yiannakopoulou, Papadopulos, Cokkinos, Mountokalakis (CR19) 2005; 12
Kearney, Whelton, Reynolds, Whelton, He (CR13) 2004; 22
van der Sande, Milligan, Nyan, Rowley, Banya, Ceesay, Dolmans, Thien, McAdam, Walraven (CR14) 2000; 14
Rm (CR16) 2002; 8
Tesfaye, Byass, Wall (CR5) 2009; 9
Pratt, Robinson, Loveday, Pellowe, Franks, Hankins, Loveday (CR11) 2001; 2
Krousel-Wood, Thomas, Muntner, Morisky (CR18) 2004; 19
Morisky, Green, Levine (CR10) 1986; 24
Lennon, Hughes, Mcelnay, Johnston (CR15) 2001; 9
Balkrishnan (CR9) 2005; 43
Hajjar, Kotchen (CR3) 2003; 290
Primatesta, Poulter (CR7) 2006; 24
Ong, Cheung, Man, Lau, Lam (CR6) 2006; 49
Hashmi, Afridi, Abbas, Sajwani, Saleheen, Frossard, Ishaq, Ambreen, Ahmad (CR8) 2007; 2
Chobanian, Bakris, Black, Cushman, Green, Izzo (CR2) 2003; 42
Kearney, Whelton, Reynolds, Muntner, Whelton, He (CR1) 2005; 365
Salako (CR4) 1993; 15
Inkster, Donnan, MacDonald, Sullivan, Fahey (CR12) 2006; 20
I Hajjar (4082_CR3) 2003; 290
Y Rm (4082_CR16) 2002; 8
E Yiannakopoulou (4082_CR19) 2005; 12
F Tesfaye (4082_CR5) 2009; 9
M Krousel-Wood (4082_CR18) 2004; 19
MA van der Sande (4082_CR14) 2000; 14
DE Morisky (4082_CR10) 1986; 24
ME Inkster (4082_CR12) 2006; 20
PM Kearney (4082_CR1) 2005; 365
RJ Pratt (4082_CR11) 2001; 2
PM Kearney (4082_CR13) 2004; 22
SK Hashmi (4082_CR8) 2007; 2
AV Chobanian (4082_CR2) 2003; 42
KL Ong (4082_CR6) 2006; 49
LA Salako (4082_CR4) 1993; 15
C Lennon (4082_CR15) 2001; 9
B Baune (4082_CR17) 2006; 5
P Primatesta (4082_CR7) 2006; 24
R Balkrishnan (4082_CR9) 2005; 43
15106785 - J Hypertens. 2004 Jan;22(1):11-9
14656957 - Hypertension. 2003 Dec;42(6):1206-52
17356691 - PLoS One. 2007;2(3):e280
3945130 - Med Care. 1986 Jan;24(1):67-74
16685220 - J Hypertens. 2006 Jun;24(6):1187-92
15218396 - Curr Opin Cardiol. 2004 Jul;19(4):357-62
16712716 - Ann Gen Psychiatry. 2006 May 19;5:6
12851274 - JAMA. 2003 Jul 9;290(2):199-206
16424861 - J Hum Hypertens. 2006 Apr;20(4):295-7
17159087 - Hypertension. 2007 Jan;49(1):69-75
15908845 - Med Care. 2005 Jun;43(6):517-20
15603041 - East Mediterr Health J. 2002 Jul-Sep;8(4-5):579-92
15942423 - Eur J Cardiovasc Prev Rehabil. 2005 Jun;12(3):243-9
19698178 - BMC Cardiovasc Disord. 2009;9:39
11590523 - HIV Clin Trials. 2001 Mar-Apr;2(2):146-59
15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23
10962516 - J Hum Hypertens. 2000 Aug;14(8):489-96
8268903 - Clin Exp Hypertens. 1993 Nov;15(6):997-1004
References_xml – volume: 49
  start-page: 69
  year: 2006
  end-page: 75
  ident: CR6
  article-title: Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000252676.46043.18
– volume: 2
  start-page: 146
  issue: 2
  year: 2001
  end-page: 159
  ident: CR11
  article-title: Adherence to Antiretroviral Therapy: Appropriate Use of Self-Reporting in Clinical Practice
  publication-title: HIV Clin Trials
  doi: 10.1310/89E2-XNJL-W107-R2GL
– volume: 290
  start-page: 199
  issue: 2
  year: 2003
  end-page: 206
  ident: CR3
  article-title: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000
  publication-title: JAMA
  doi: 10.1001/jama.290.2.199
– volume: 12
  start-page: 243
  issue: 3
  year: 2005
  end-page: 249
  ident: CR19
  article-title: Adherence to antihypertensive treatment: a critical factor for blood pressure control
  publication-title: Eur J Cardiovasc Prev Rehabil
  doi: 10.1097/00149831-200506000-00010
– volume: 22
  start-page: 11
  issue: 1
  year: 2004
  end-page: 19
  ident: CR13
  article-title: Worldwide prevalence of hypertension: a systematic review
  publication-title: J Hypertens
  doi: 10.1097/00004872-200401000-00003
– volume: 19
  start-page: 357
  issue: 4
  year: 2004
  end-page: 362
  ident: CR18
  article-title: Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients
  publication-title: Curr Opin Cardiol
  doi: 10.1097/01.hco.0000126978.03828.9e
– volume: 14
  start-page: 489
  issue: 8
  year: 2000
  end-page: 496
  ident: CR14
  article-title: Blood pressure patterns and cardiovascular risk factors in rural and urban gambian communities
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001050
– volume: 42
  start-page: 1206
  issue: 6
  year: 2003
  end-page: 1252
  ident: CR2
  article-title: Jones DW, Materson BJ, Oparil S, Wright JT Jr, et al: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000107251.49515.c2
– volume: 15
  start-page: 997
  issue: 6
  year: 1993
  end-page: 1004
  ident: CR4
  article-title: Hypertension in Africa and Effectiveness of Its Management with Various Classes of Antihypertensive Drugs and in Different Socio-Economic and Cultural Environments
  publication-title: Clin Exp Hypertens
  doi: 10.3109/10641969309037087
– volume: 43
  start-page: 517
  issue: 6
  year: 2005
  end-page: 520
  ident: CR9
  article-title: The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know
  publication-title: Med Care
  doi: 10.1097/01.mlr.0000166617.68751.5f
– volume: 9
  start-page: 39
  year: 2009
  ident: CR5
  article-title: Population based prevalence of high blood pressure among adults in Addis Ababa: uncovering a silent epidemic
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/1471-2261-9-39
– volume: 24
  start-page: 67
  issue: 1
  year: 1986
  end-page: 74
  ident: CR10
  article-title: Concurrent and predictive validity of a self-reported measure of medication adherence
  publication-title: Med Care
  doi: 10.1097/00005650-198601000-00007
– volume: 8
  start-page: 579
  issue: 4–5
  year: 2002
  end-page: 592
  ident: CR16
  article-title: II M: Patterns and determinants of treatment compliance among hypertensive patients
  publication-title: East Mediterr Health J
– volume: 2
  start-page: e280
  issue: 3
  year: 2007
  ident: CR8
  article-title: Factors associated with adherence to anti-hypertensive treatment in Pakistan
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000280
– volume: 365
  start-page: 217
  issue: 9455
  year: 2005
  end-page: 223
  ident: CR1
  article-title: Global burden of hypertension: analysis of worldwide data
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)70151-3
– volume: 5
  start-page: 6
  year: 2006
  ident: CR17
  article-title: The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip
  publication-title: Ann Gen Psychiatr
  doi: 10.1186/1744-859X-5-6
– volume: 24
  start-page: 1187
  issue: 6
  year: 2006
  end-page: 1192
  ident: CR7
  article-title: Improvement in hypertension management in England: results from the Health Survey for England 2003
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000226210.95936.bc
– volume: 9
  start-page: 8
  issue: s1
  year: 2001
  ident: CR15
  article-title: Identification of psychosocial factors which influence patient adherence with antihypertensive medication
  publication-title: Int J Pharm Pract
  doi: 10.1111/j.2042-7174.2001.tb01068.x
– volume: 20
  start-page: 295
  issue: 4
  year: 2006
  end-page: 297
  ident: CR12
  article-title: Adherence to antihypertensive medication and association with patient and practice factors
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001981
– volume: 24
  start-page: 1187
  issue: 6
  year: 2006
  ident: 4082_CR7
  publication-title: J Hypertens
  doi: 10.1097/01.hjh.0000226210.95936.bc
– volume: 8
  start-page: 579
  issue: 4–5
  year: 2002
  ident: 4082_CR16
  publication-title: East Mediterr Health J
– volume: 22
  start-page: 11
  issue: 1
  year: 2004
  ident: 4082_CR13
  publication-title: J Hypertens
  doi: 10.1097/00004872-200401000-00003
– volume: 43
  start-page: 517
  issue: 6
  year: 2005
  ident: 4082_CR9
  publication-title: Med Care
  doi: 10.1097/01.mlr.0000166617.68751.5f
– volume: 290
  start-page: 199
  issue: 2
  year: 2003
  ident: 4082_CR3
  publication-title: JAMA
  doi: 10.1001/jama.290.2.199
– volume: 14
  start-page: 489
  issue: 8
  year: 2000
  ident: 4082_CR14
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001050
– volume: 9
  start-page: 8
  issue: s1
  year: 2001
  ident: 4082_CR15
  publication-title: Int J Pharm Pract
  doi: 10.1111/j.2042-7174.2001.tb01068.x
– volume: 365
  start-page: 217
  issue: 9455
  year: 2005
  ident: 4082_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)70151-3
– volume: 24
  start-page: 67
  issue: 1
  year: 1986
  ident: 4082_CR10
  publication-title: Med Care
  doi: 10.1097/00005650-198601000-00007
– volume: 42
  start-page: 1206
  issue: 6
  year: 2003
  ident: 4082_CR2
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000107251.49515.c2
– volume: 15
  start-page: 997
  issue: 6
  year: 1993
  ident: 4082_CR4
  publication-title: Clin Exp Hypertens
  doi: 10.3109/10641969309037087
– volume: 19
  start-page: 357
  issue: 4
  year: 2004
  ident: 4082_CR18
  publication-title: Curr Opin Cardiol
  doi: 10.1097/01.hco.0000126978.03828.9e
– volume: 12
  start-page: 243
  issue: 3
  year: 2005
  ident: 4082_CR19
  publication-title: Eur J Cardiovasc Prev Rehabil
  doi: 10.1097/00149831-200506000-00010
– volume: 49
  start-page: 69
  year: 2006
  ident: 4082_CR6
  publication-title: Hypertension
  doi: 10.1161/01.HYP.0000252676.46043.18
– volume: 2
  start-page: 146
  issue: 2
  year: 2001
  ident: 4082_CR11
  publication-title: HIV Clin Trials
  doi: 10.1310/89E2-XNJL-W107-R2GL
– volume: 9
  start-page: 39
  year: 2009
  ident: 4082_CR5
  publication-title: BMC Cardiovasc Disord
  doi: 10.1186/1471-2261-9-39
– volume: 5
  start-page: 6
  year: 2006
  ident: 4082_CR17
  publication-title: Ann Gen Psychiatr
  doi: 10.1186/1744-859X-5-6
– volume: 2
  start-page: e280
  issue: 3
  year: 2007
  ident: 4082_CR8
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0000280
– volume: 20
  start-page: 295
  issue: 4
  year: 2006
  ident: 4082_CR12
  publication-title: J Hum Hypertens
  doi: 10.1038/sj.jhh.1001981
– reference: 15106785 - J Hypertens. 2004 Jan;22(1):11-9
– reference: 19698178 - BMC Cardiovasc Disord. 2009;9:39
– reference: 15908845 - Med Care. 2005 Jun;43(6):517-20
– reference: 16424861 - J Hum Hypertens. 2006 Apr;20(4):295-7
– reference: 8268903 - Clin Exp Hypertens. 1993 Nov;15(6):997-1004
– reference: 14656957 - Hypertension. 2003 Dec;42(6):1206-52
– reference: 17356691 - PLoS One. 2007;2(3):e280
– reference: 11590523 - HIV Clin Trials. 2001 Mar-Apr;2(2):146-59
– reference: 16712716 - Ann Gen Psychiatry. 2006 May 19;5:6
– reference: 12851274 - JAMA. 2003 Jul 9;290(2):199-206
– reference: 15603041 - East Mediterr Health J. 2002 Jul-Sep;8(4-5):579-92
– reference: 15942423 - Eur J Cardiovasc Prev Rehabil. 2005 Jun;12(3):243-9
– reference: 3945130 - Med Care. 1986 Jan;24(1):67-74
– reference: 10962516 - J Hum Hypertens. 2000 Aug;14(8):489-96
– reference: 16685220 - J Hypertens. 2006 Jun;24(6):1187-92
– reference: 15218396 - Curr Opin Cardiol. 2004 Jul;19(4):357-62
– reference: 15652604 - Lancet. 2005 Jan 15-21;365(9455):217-23
– reference: 17159087 - Hypertension. 2007 Jan;49(1):69-75
SSID ssj0017852
Score 2.3651307
Snippet Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia...
Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia and 30% in...
Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia...
Doc number: 282 Abstract Background : Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is...
BACKGROUND: Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in Ethiopia...
Abstract Background Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The prevalence of HTN is estimated to be 6% in...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 282
SubjectTerms Adolescent
Adult
Analysis
Antihypertensive Agents - economics
Antihypertensive Agents - therapeutic use
Antihypertensive drugs
Antihypertensives
Biostatistics
Blood pressure
Blood Pressure - physiology
Care and treatment
Chronic Disease - epidemiology
Chronic illnesses
Comorbidity
Confidence intervals
Counseling
Cross-Sectional Studies
Data collection
Drug therapy
Environmental Health
Epidemiology
Ethiopia
Ethiopia - epidemiology
Ethnic Groups - psychology
Ethnic Groups - statistics & numerical data
Female
Follow-Up Studies
Health aspects
Health care policy
Health Knowledge, Attitudes, Practice
Hospitals, University
Humans
Hypertension
Hypertension - diagnosis
Hypertension - drug therapy
Hypertension - epidemiology
Logistic Models
Male
Medical referrals
Medication Adherence - psychology
Medication Adherence - statistics & numerical data
Medicine
Medicine & Public Health
Middle Aged
Morbidity
Mortality
Patient compliance
Patient education
Patients
Population
Prevalence
Prevalence studies (Epidemiology)
Public Health
Quality of life
Questionnaires
Research Article
Sociodemographics
Socioeconomic Factors
Surveys and Questionnaires
Teaching hospitals
Vaccine
Young Adult
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9yT4KI31ZPiSCIYtl-JG0Cvqziefjgkwf3FpJ2yi4c7XLXxT_Df9mZNK2b88QXnxaahE0y08lvOpPfMPZa-kOocKmSjU1FVUKqrSpTUBLhuawz6zzb57fq9Ex8PZfnB6W-KCdsogeeNm4FSgntcgDrcgGqcFpVtqwLCxbRsPI8n5nOZmcqxA9q5Wvt5Gh600JINQcoVbVanlFSQkEEfNFN94vogPI8_n9a64Pj6noq5bV4qj-mTu6xuwFf8vW0rvvsFvQP2J3p4xyf7hw9ZD_X7Wa65sfHgePebjfojl6GZHa-JJ9jU8ttECC0PBTn4b5CEQ-UrFd86HmH6jT84PsdtyP_nezBh45_GehbBZ8LlLznPlREDA2cku2H3dY-Ymcnn79_Ok1DZYbUVVKPqRPK5a1rpeygUAibmgygaW0tm9qhE-naDkBa6GQhrNUd2EoQElRUbV0j4nrMjvqhh6eMQ1WotuksDqlE1Xb4q0RjIcchtRUuYR8i8ZjdxMJhiBc7bsFX1JB0DUnX5IVB6SZsNUvTNIH1nIpvXBjv_ajqhhFvlxHzf_2970dSkGhO_gFqsAkabP6lwQl7Q-plyKLg1BobLkbg_hA3l1lLRBpSoaVM2HHUEy1BEzfPCmqCJbrCqSNARZ-ylgl7tTTTSMqu62HYYx-Klua5FtjnyaTPy5IQ4mmKbiesjjQ9WnPc0m83nqe8LLVEbyFh7-Z34nBaN-_os_-xo8_ZbcS1BQX98uyYHY2Xe3iB2HF0L72Z-AXl72vj
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1di9QwMOj5Ioj4bfWUCIIoltumSZuCIKu4d_jgkwf3FpJ06i4c7brbxZ_hX3YmTfeu5-nTQpNhk8x3ZjLD2GsVlJBwqVbeprLIIa2szlPQCs1zVc6sC9U-vxUnp_LrmTqLF27bmFY5ysQgqOvO0x05cjcqWrSNS_Vx_TOlrlEUXY0tNG6yWxlqGqJzvTjeRxFKrcQYmtTFUYaCOBVSaUpHEFR6b_LG_XyimkIF_7_l9CVFdTWJ8kokNSioxT12N1qWfD6Qwn12A9oH7M5wLceH10YP2e95vRwe-PG-43iqqyU6opuYxs73aec4VHMbUQc1j215eOhNxGMx1i3vWt4gIXW_-G7Nbc8v0jx41_Djjm4p-Nia5D0PQSKqzcApzb5br-wjdrr48v3zSRp7MqSuUFWfOqldVrtaqQaERoPJzwB8bUvlS4fuo6sbAGWhUUJaWzVgC0k2oKY-6xXaWo_ZQdu18JRxKISufWMRpJBF3eCvlt5ChiCllS5hHyboMeuh_oahitjTESQUQ9g1hF2TCYPYTdjRiE3jY71zartxboLfo4trIN7uIcb_-vfcT0QgkzWFD93mh4lMb0BrWbkMwLpMghau0oXNS2HBoien84S9IfIyJEtwad7GJxF4PlSVy8wV2hhKo4xM2OFkJsoAPx0eCdREGbQ1FxyTsFf7YYKkvLoWuh3OoThpllUS5zwZ6Hm_JTTuKoprJ6ycUPpkz9ORdrUMFcrzvFLoJyTs3cgTl5d1_Yk--_8enrPbaKsKCuRls0N20G928ALtwd69DEz_B-XQYWM
  priority: 102
  providerName: ProQuest
– databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1di9QwcDhPEEFEz6_qKREEUSy3TZM2BV9W8TwEfXLh3kLSTt2Fo132utzPuL_sJE3rdV0ffFrozLBpZjKZ6XwBvJH-EuI2VrI0schSjAuj0hiVJPNc5jNjfbfPH9nZQnw7l-cHwIdaGJ_tPoQkvab2x1plJwmp0ZgLqVwyATkKt-C2JM_dHcYFn4-Rg1xJPoQj91Dt1LVfTK4j37X_b91843LaTZzciZ76S-n0AdwP1iSb9-x_CAfYHMGd7yFefgT3-q9yrC82egTX82rZ1_exrmW0qasl-aGbkMXOxqxzAlXMBM5hxcJUHuZHE7HQi_WStQ2rSY7aK7ZdM9OxP1kerK3Z19Z9pGDDZJIPzMeIXGsG5rLs2_XKPIbF6Zefn8_iMJIhtpksutgKZZPKVlLWyBXZS-UMsaxMLsvckvdoqxpRGqwlF8YUNZpMOBNQuTHrBZlaT-CwaRt8BgwzrqqyNkSSiayq6VeJ0mBCJLkRNoKPE07pdd9-Q7uG2FMIiYl2jNaO0TrhmhgdwcnAWF2Gdudu6saF9m6PyvZQvBsphv_6N-4nJyuTNfkH7eaXDmdeo1KisAmisYlAxW2hMpPm3KAhR06lEbx1kqadKqGllSZURND-uKZcei7JxJCKVGQExxNMUgHlFDzIqg4q6JKWTpYpOZO5jOD1CHaULq2uwXZLOC5MmiSFIJynvWiPr0S2XeHC2hHkE6GfvPMU0qyWvkF5mhaS3IQI3g_H4-ay9u_o8_9BfgF3yXDlLqqXzI7hsNts8SUZh5195bXBb5APYEc
  priority: 102
  providerName: Springer Nature
Title Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia
URI https://link.springer.com/article/10.1186/1471-2458-12-282
https://www.ncbi.nlm.nih.gov/pubmed/22490130
https://www.proquest.com/docview/1027376875
https://www.proquest.com/docview/1551611945
http://dx.doi.org/10.1186/1471-2458-12-282
https://pubmed.ncbi.nlm.nih.gov/PMC3395566
https://doaj.org/article/e8849b1eeab14e82b986a372aea25583
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1dixMxMHh3L4KI366eJYIgiut1d5NsFhRpy_UOwUMOC8WXkOxmbaHs1l6L-iv8y85kP3pb65MvKe1MttnMZDKTmcwQ8oK7TSg0vuSp9pmIrJ9oGflWclDPedzXxmX7vBDnE_Zxyqfb69H1BF7tNe2wntRktXj78_uvD7Dg37sFL8VJAALWDxmXGGYAJsQBOYJ9SaAp9oltfQqxdPV3WuzGabnnCTu33xedTcvl9v9bgl_bwnbDK3d8rG7rGt8ht2udkw4qJrlLbtjiHrlVHdjR6h7SffJ7kM2qq390XVKY7_kMTNRVHeBO24B0AGVU10S1Ga0L9lBXtYjWaVqvaFnQHFis_EE3S6rXdBsAQsucnpV4fkGboiVvqHMfYdYGigH45XKuH5DJ-PTL6NyvqzX4RvBk7RsmTZCZjPPchhJUqbRvbZrpmKexAcPSZLm1XNuch0zrJLdaMNQOJVZgT0ALe0gOi7Kwjwm1IpRZmmvoIpjIcviULNU2gC6xZsYj7zrkUcsqM4fCXNldCCxbhdRVSF0VhAqo65GThpoqrTOhY0GOhXIWkRR7erxqezT_9W_cITJIZ0zuh3L1TdXiQFkpWWICa7UJmJWhSaTQURxqq8HGk5FHXiJ7KeR7GFqq68sSMD-Yr0sNOGgfXIL09MhxBxOkQ9oFNwyqmsUFQwelFezMmHvkeQvGnhhxV9hyAzjoQQ2ChAHOo4qf21cCtS9Bj7dH4g6nd965CynmM5e7PIoSDhaER143a-L6sPbP6JP_I_dTchO03BBdgEH_mByuVxv7DDTJtemRg3gaQytHAbbjsx45Gp5efL6EbyMx6rkTmp4TI9BeDr9COwkHfwA2HXny
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqcgAJId4EChgJhEBE3Th24kggtDzKlpaeWqk3104m7EpVsuxDFb-Cf8JvZMZJtk0p3HqKFNuKnRl_M-MZzzD2XHkhJFyoVW5DmcQQZlbHIWiF6rlKB9b5bJ97yehAfj1Uh2vsd3cXhsIqO0z0QF3UOZ2R4-5GQYu6careT3-EVDWKvKtdCY2GLXbg5wmabPN325-Qvi-E2Pq8_3EUtlUFQpeobBE6qV1UuEKpEoRGkZ8PAPLCpipPHRpArigBlIVSCWltVoJNJGkxmiqFZwklOkDIvyLpZBz3T3q4MvCo0L3oXKE62YwQ-EMhlabwB0Gp_np36o97otBXDPhbLpwRjOeDNs95br1A3LrJbrSaLB82rHeLrUF1m11vjgF5c7vpDvs1LMbNhUK-qDlScTJGw3fWhs3zVZg7NhXctqwCBW_LAHFfC4m3yV_nvK54iYxbn_DllNsFPw0r4XXJv9R0KsK7UihvuHdKUS4ITmH99XRi77KDS6HWPbZe1RU8YBwSoYu8tDgkkUlR4lPL3EKEQ1IrXcDe9shjpk2-D0MZuPstyJiGqGuIuiYSBqkbsM2OmiZv86tTmY9j4-0snVww4tVqRPetf_f9QAzSm5N_Uc--mxZkDGgtMxcBWBdJ0MJlOrFxKixYtBx1HLCXxF6GsAunltv2Cgb-H8oCZoYKdRqlEZMDttHriZiT95s7BjUt5s3N6Q4N2LNVM42kOL4K6iX2Ib9sFGUS-9xv-Hm1JFQmM_KjByztcXpvzf2WajL2GdHjOFNolwTsdbcnzk7r4j_68P9reMqujva_7Zrd7b2dR-wa6smCnIjRYIOtL2ZLeIy66MI98QDA2dFlI84fkVOfig
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1di9QwcNATDkEOPb96nhpBEMWy2zZJU_BlPV3Pr8MHD-4tJG3qLhztstvFn-FfdqZN1-u6PvhUaGZomplMZjJfAM9FewjFNlQiNyGXiQszo5LQKYHquUjHxrbVPs_k6Tn_dCEu_IXbqo92712SXU4DVWmqmtGiKLstruQoQpEaxlwoCixAo-E63OD0TXLWypONFyFVIu5dkzuwtnLcLwdHU1vB_285feWg2g6i3PKktgfU9DYceM2STTpWuAPXXHUI-1-97_wQbnU3dKxLPLoLvybFrMv1Y03NcIHnM7RJlz6inW0i0HGoYMZT0RXMd-hhbZsi5uuyrlhdsRJ5qv7J1gtmGvYn4oPVJftQ04UF67uUvGatv4jKNDCKuK8Xc3MPzqfvv5-chr49Q2ilyJrQcmWjwhZClC5WqDvlY-fywqQiTy1akrYonRPGlSLmxmSlM5KTOqio5XqGatd92Kvqyj0E5mSsirw0iCK5LEp8Kp4bFyFKargN4M2AUnrRleLQVBx7OIIso4nQmgito1gjoQMY9YTVuS99Th04LnVrAim5A-PlBqP_1r9h3xKvDObUvqiXP7Tf_9opxTMbOWdsxJ2KbaakSdLYOINGnUoCeEGcpkms4NRy47MjcH2oQJeeCFQ3hEJxGcDxABLFQT4c7nlVe3G0wqmjloqGZSoCeLYZJkwKsatcvUYYcplGUcYR5kHH2ptfQj0vIxd3AOmA6Qf_PByp5rO2WHmSZAJNhgBe9dvj6rR2r-jR_wA_hf1v76b6y8ezz4_gJuqzMTn7ovEx7DXLtXuMOmNjn7SC4Tdw72dg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Adherence+to+antihypertensive+treatment+and+associated+factors+among+patients+on+follow+up+at+University+of+Gondar+Hospital%2C+Northwest+Ethiopia&rft.jtitle=BMC+public+health&rft.au=Ambaw%2C+Abere&rft.au=Alemie%2C+Getahun&rft.au=W%2FYohannes%2C+Solomon&rft.au=Mengesha%2C+Zelalem&rft.date=2012-04-10&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2458&rft.eissn=1471-2458&rft.volume=12&rft.issue=1&rft.spage=282&rft.epage=282&rft_id=info:doi/10.1186%2F1471-2458-12-282&rft.externalDBID=n%2Fa&rft.externalDocID=oai_biomedcentral_com_1471_2458_12_282
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2458&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2458&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2458&client=summon